1,4-3,6-dianhydromannitol has been researched along with Glaucoma, Suspect in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, F; Almirante, N; Bastia, E; Bergamini, MVW; Brambilla, S; Galli, C; Impagnatiello, F; Masini, E; Navratil, T; Sgambellone, S; Toris, CB; Torrejon, KY; Unser, AM | 1 |
1 other study(ies) available for 1,4-3,6-dianhydromannitol and Glaucoma, Suspect
Article | Year |
---|---|
NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs.
Topics: Animals; Aqueous Humor; Bridged Bicyclo Compounds, Heterocyclic; Cyclic GMP; Disease Models, Animal; Dogs; Female; Intraocular Pressure; Limbus Corneae; Macaca fascicularis; Nitric Oxide Donors; Ocular Hypertension; Rabbits; Trabecular Meshwork; Transforming Growth Factor beta2 | 2021 |